Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays

P. Wallemacq, J. S. Goffinet, H. Ait-Youcef

Ann Transplant 2008; 13(1): 37-38 :: ID: 880197

Abstract

Background: The purpose of this study was to evaluate relative performances of the ARCHITECT and DIMENSION immunoassays, the first requiring preanalytical pretreatment, the last one not.
Material/Methods: Method comparison analyses were performed by testing specimens from transplant recipients. The functional sensitivities (LOQ) of the ARCHITECT and DIMENSION were assessed by testing whole blood specimens spiked with tacrolimus or cyclosporine, run in replicates of 10 on two consecutive days on both instruments. Metabolite cross-reactivity was measured directly in whole blood containing a target concentration of 200 ng/mL cyclosporine and 1,000 ng/mL purified cyclosporine metabolites (AM1, AM1c, AM4N, AM9, AM19). Hematocrit levels were recorded.
Results: The following results were obtained in patient correlation studies: ARCHITECT vs DIMENSION tacrolimus (n=197) Spearman r=0.95, y=0.98x - 0.27 and an average bias of -0.46 ng/mL; ARCHITECT vs DIMENSION cyclosporine (n=95) Spearman r=0.94, y=x - 20 and an average bias of -20.8ng/mL. The LOQ (20%CV) for tacrolimus was 0.6 ng/mL vs 3.1 ng/mL on the ARCHITECT vs DIMENSION, respectively. For cyclosporine these values were 12.1 ng/mL vs 28 ng/mL, respectively for ARCHITECT vs Dimension. Statistical analysis of the 3 ng/mL functional sensitivity panel yielded the following results: ARCHITECT, mean =3.03 ng/mL (95% CI=2.71-3.36); DIMENSION, mean =2.80 ng/mL (95% CI=1.44-4.15). Cyclosporine metabolite cross-reactivity ranged from -0.8% up to 2.2% for the ARCHITECT and from -0.1 up to 6.4% for the DIMENSION, respectively. Hematocrit did not affect any of these assays.
Conclusions: Both assays displayed satisfactory analytical performances. However, from these data, it is suggested that the preanalytical steps involved in the ARCHITECT as says might contribute positively in their analytical performances (particularly the LOQ) as compared to the fully automated DIMENSION.

Keywords: -----, bladder tissue, electrical impedance, first record-able reading, optimal probe pressure, Tacrolimus

0 Comments

In Press

20 Jan 2022 : Original article  

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Ki...

Ann Transplant In Press; DOI: 10.12659/AOT.934850  

19 Jan 2022 : Original article  

Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in He...

Ann Transplant In Press; DOI: 10.12659/AOT.933420  

18 Jan 2022 : Original article  

PLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells

Ann Transplant In Press; DOI: 10.12659/AOT.933246  

17 Jan 2022 : Original article  

Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center

Ann Transplant In Press; DOI: 10.12659/AOT.934988  

Most Viewed Current Articles

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

22 Dec 2021 : Original article  

Comparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...

DOI :10.12659/AOT.934163

Ann Transplant 2021; 26:e934163

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358